UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)

(Exact name of registrant as specified in charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code
not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading |
Name of each exchange | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 under the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 8.01. | Other Events. |
On November 18, 2026, the board of directors (the “Board”) of Air Products and Chemicals, Inc. (the “Company”), upon the recommendation of its Corporate Governance and Nominating Committee (the “Committee”), announced that it would nominate Carol Williams for election to the Board at the Company’s 2027 Annual Meeting of Shareholders (the “Annual Meeting”). Ms. Williams has extensive chemical industry experience, including senior leadership roles at The Dow Chemical Company, where she previously served as Special Advisor to the Chief Executive Officer; Executive Vice President of Manufacturing and Engineering, Supply Chain and Environmental, Health and Safety Operations; President of Chemicals and Energy; Senior Vice President of Basic Chemicals; and Corporate Vice President of Market Facing, Business Development and Licensing Portfolio. Ms. Williams also serves on the boards of directors of Olin Corporation, where she chairs the Nominating and Governance Committee, and O-I Glass Inc.
In addition to Ms. Williams, the Board, upon recommendation of the Committee, nominated eight current directors, Tonit M. Calaway, Andrew “Drew” W. Evans, Paul C. Hilal, Eduardo Menezes, Dennis H. Reilley, Wayne T. Smith, Alfred Stern and Howard Ungerleider, for re-election at the Annual Meeting. Two incumbent directors, Jessica Trocchi Graziano and Bhavesh V. (“Bob”) Patel will not stand for re-election at the Annual Meeting and will retire from the Board when their terms conclude. Following the Annual Meeting, the size of the Board will be reduced to nine directors. There are no disagreements between the Company and Ms. Graziano or Mr. Patel on any matter relating to the Company’s operations, policies or practices that resulted in their decision not to stand for re-election and to retire from the Board at the conclusion of the Annual Meeting.
On November 18, 2026, the Company issued a press release regarding Ms. Williams’ nomination and Ms. Graziano’s and Mr. Patel’s decisions not to stand for re-election at the Annual Meeting. A copy of the press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference.
Important Information and Where to Find It.
The Company plans to file a definitive proxy statement with the U.S. Securities and Exchange Commission (the “SEC”) in connection with the solicitation of proxies for the Annual Meeting. Shareholders are advised to read the proxy statement (including any amendments or supplements thereto) and any other relevant documents that the Company files with the SEC relating to the Annual Meeting, as such materials will contain important information. Shareholders will be able to obtain, free of charge, copies of the proxy statement, any amendments or supplements thereto and any other documents (including the proxy card) when filed by the Company with the SEC at the SEC’s website, www.sec.gov, or at the Company’s website, https://investors.airproducts.com/.
Certain Information Regarding Participants
The Company, its directors and certain of its executive officers and other employees may be deemed to be “participants” (as defined in Section 14(a) of the Securities Exchange Act of 1934) in the solicitation of proxies from shareholders in connection with the Annual Meeting. Additional information regarding the identity of these potential participants and their direct or indirect interests, by security holdings or otherwise, will be set forth in the Company’s definitive proxy statement to be filed with the SEC in connection with the Annual Meeting and is also available in the Company’s prior filings and the Section 16 filings of the Company’s directors and executive officers, which are available free of charge on the websites of the SEC and the Company that are referenced above.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
| Exhibit No. |
Description | |
| 99.1 | Press Release of Air Products and Chemicals, Inc. dated November 18, 2026. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Air Products and Chemicals, Inc. (Registrant) | ||||||
| Date: November 18, 2026 | By: | /s/ Matthew Lepore | ||||
| Matthew Lepore | ||||||
| Executive Vice President, General Counsel, | ||||||
| Chief Compliance Officer and Secretary | ||||||